Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gendron

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Molecular Neurodegeneration|March 13, 2025
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disordersUdit Sheth, Linn Öijerstedt, Michael G Heckman, et al.
Annals of Clinical and Translational Neurology|May 16, 2018
Poly(GP), neurofilament and grey matter deficits in <i>C9orf72</i> expansion carriersLieke H H Meeter, Tania F Gendron, Ana C Sias, et al.
The Journal of Clinical Investigation|August 14, 2020
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementiaMercedes Prudencio, Jack Humphrey, Sarah Pickles, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Gene specific effects on brain volume and cognition of <i>TMEM106B</i> in frontotemporal lobar degenerationMarijne Vandebergh, Eliana Marisa Ramos, Nick Corriveau-Lecavalier, et al.
Science Translational Medicine|October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
Nature Medicine|September 22, 2022
Temporal order of clinical and biomarker changes in familial frontotemporal dementiaAdam M Staffaroni, Melanie Quintana, Barbara Wendelberger, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 2022
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> diseaseMelanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, et al.
Molecular Neurodegeneration|March 13, 2025
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disordersUdit Sheth, Linn Öijerstedt, Michael G Heckman, et al.
Annals of Clinical and Translational Neurology|May 16, 2018
Poly(GP), neurofilament and grey matter deficits in <i>C9orf72</i> expansion carriersLieke H H Meeter, Tania F Gendron, Ana C Sias, et al.
The Journal of Clinical Investigation|August 14, 2020
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementiaMercedes Prudencio, Jack Humphrey, Sarah Pickles, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Gene specific effects on brain volume and cognition of <i>TMEM106B</i> in frontotemporal lobar degenerationMarijne Vandebergh, Eliana Marisa Ramos, Nick Corriveau-Lecavalier, et al.
Science Translational Medicine|October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
Science Translational Medicine|March 31, 2017
Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.
Nature Medicine|September 22, 2022
Temporal order of clinical and biomarker changes in familial frontotemporal dementiaAdam M Staffaroni, Melanie Quintana, Barbara Wendelberger, et al.
Pageof 14